Fulfilling the potential of life-saving medications
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs using our proprietary vivoXPRESS® platform. The plant-based vivoXPRESS® system makes it easier, faster and less expensive to produce approved biologic drugs for novel indications and new markets.
PlantForm's pipeline includes:
trastuzumab for a novel indication in nerve regeneration after acute trauma
biosimilar versions of Lucentis® and other niche indication drugs
medical countermeasures to terrorism threats such as ricin and sarin
innovator antibodies for HIV/AIDS (R&D funded by the Gates Foundation and the Government of Canada), and
innovator antibodies for treatment of Ebola virus (Sudan strain).
Site Design by RKD Web Studios